DI SEBASTIANO, PIERLUIGI
 Distribuzione geografica
Continente #
NA - Nord America 3.024
EU - Europa 2.045
AS - Asia 582
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
AF - Africa 2
SA - Sud America 2
Totale 5.667
Nazione #
US - Stati Uniti d'America 3.016
IE - Irlanda 484
UA - Ucraina 332
SE - Svezia 323
IT - Italia 316
CN - Cina 302
GB - Regno Unito 210
TR - Turchia 168
DE - Germania 154
FR - Francia 100
IN - India 76
FI - Finlandia 48
BE - Belgio 20
VN - Vietnam 18
AT - Austria 11
NL - Olanda 8
EU - Europa 7
CA - Canada 6
IL - Israele 5
BG - Bulgaria 4
ES - Italia 4
RU - Federazione Russa 4
AU - Australia 3
EE - Estonia 3
GR - Grecia 3
PT - Portogallo 3
RO - Romania 3
BR - Brasile 2
CH - Svizzera 2
GL - Groenlandia 2
JP - Giappone 2
KW - Kuwait 2
LU - Lussemburgo 2
PL - Polonia 2
RS - Serbia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BT - Bhutan 1
DK - Danimarca 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
LT - Lituania 1
MD - Moldavia 1
ME - Montenegro 1
MT - Malta 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SC - Seychelles 1
SG - Singapore 1
TH - Thailandia 1
Totale 5.667
Città #
Chandler 842
Dublin 479
Jacksonville 459
Ashburn 237
Princeton 224
Southend 157
Wilmington 121
Izmir 93
Beijing 85
Nanjing 83
Chieti 80
Dearborn 75
Altamura 72
Cambridge 51
Washington 49
Ann Arbor 46
Boardman 34
Woodbridge 34
Los Angeles 26
New York 25
Nanchang 22
Brussels 20
Houston 17
Dong Ket 16
Falls Church 16
Shenyang 16
Edinburgh 12
Kunming 12
Tianjin 12
Grevenbroich 11
Vienna 11
Vittuone 11
Jiaxing 10
Pune 10
Hebei 9
Norwalk 9
Hefei 8
London 8
Pescara 8
Fairfield 7
Rome 7
Seattle 7
Amsterdam 6
Redmond 6
Saint Louis 6
Arcore 5
Bologna 5
Francavilla al Mare 5
Hangzhou 5
Redwood City 5
Boston 4
Jinan 4
Kocaeli 4
Ningbo 4
Sofia 4
Toronto 4
Augusta 3
Bari 3
Cedar Knolls 3
Changsha 3
Dallas 3
Frankfurt am Main 3
Guangzhou 3
Istanbul 3
Leawood 3
L’Aquila 3
Madrid 3
Orange 3
Porto 3
San Mateo 3
Taizhou 3
Tallinn 3
Zhengzhou 3
Auburn Hills 2
Bangalore 2
Belgrade 2
Brescia 2
Bucharest 2
Cepagatti 2
Chicago 2
Civitella Del Tronto 2
Grafing 2
Haikou 2
Hanoi 2
Helsinki 2
Kuwait City 2
Lecco 2
Luxembourg 2
New Orleans 2
Nuuk 2
Salerno 2
San Jose 2
Santa Clara 2
Shaoxing 2
Stockholm 2
Sydney 2
São Paulo 2
Taipei 2
Tel Aviv 2
Tokyo 2
Totale 3.703
Nome #
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma 124
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 98
MICROSATELLITE ALTERATIONS IN PANCREATIC CARCINOMA 96
Totally laparoscopic complete mesocolon excision for splenic flexure cancer. A single institution experience 94
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 82
BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages 81
Beneficial effects of BB-94, a matrix metalloproteinase inhibitor, in rat experimental colitis 80
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 76
[Carcinoma of the male breast. Our experience]. 76
Developing a Decision-making Model Based on an Interdisciplinary Oncological Care Group for the Management of Colorectal Cancer 74
Batimastat, A Matrix Metalloproyeinase inhibitor accellerates Healing in Rat Experimental Colitis 73
Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells 72
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 70
Beneficial Effects of Batimastat (bb-94), a Matrix Metalloproteinase Inhibitor, in Rat Experimental Colitis 69
[Laparoscopic adrenalectomy: analysis of 65 cases] 69
Totally laparoscopic complete mesocolon excision for splenic flexure cancer 68
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer 66
Espressione del Connective Tissue Growth Factor (CTGF) nel cancro pancreatico 65
Combined therapy in pancreatic cancer 64
Methylation analysis of protocadherin genes in pancreatic adenocarcinoma 63
Tumor detectability and conspicuity comparison of standard b1000 and ultrahigh b2000 diffusion-weighted imaging in rectal cancer 63
Full Robotic Distal Pancreatectomy: Safety and Feasibility Analysis of a Multicenter Cohort of 236 Patients 63
A surgical department for intensified care 63
Extracorporeal versus intracorporeal anastomosis after laparoscopic right hemicolectomy: cost-effectiveness analysis 63
Haemorrhoids and transient receptor potential vanilloid 1 63
Appendicitis: the role of nerves in pain generation 61
Endoscopic therapy for type B surgical biliary injury in a patient with short cystic duct. 61
Changes in cytokine but not tachynin gene expression in patients with chronic pancreatitis 59
Growth-associated protein-43 and protein gene-product 9.5 innervation in human pancreas: changes in chronic pancreatitis 59
Altered anti-inflammatory response of mononuclear cells to neuropeptide PACAP is associated with deregulation of NF-κB in chronic pancreatitis 59
Interleukin 8 gene expression is increased in patients with chronic pancreatitis (pubbl. su Digestion). 58
Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: A systematic analysis of benefits and associated risks 58
Time-qualified patterns of variation of PPAR γ, DNMT1, and DNMT3B expression in pancreatic cancer cell lines 58
Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients 58
Alterations of dna-repeats in pancreatic cancer 58
The techniques of duodenum preserving head resection of the pancreas in the treatment of chronic pancreatitis 58
Influenza dei neurotrasmettitori algogeni sulla crescita cellulare nel cancro del pancreas 57
Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: A meta-analysis of prospective studies 57
Mirna expression profiles identify drivers in colorectal and pancreatic cancers 57
TRANSFORMING GROWTH FACTOR-BETA PATHWAY IS ACTIVATED IN CHOLECYSTOLITHIASIS 56
The Pituitary Adenylate Cyclase-Activating Polypeptide Pathway is Activated in Human Chronic Pancreatitis. 56
BAG3 is a novel serum biomarker for pancreatic adenocarcinomas. 56
Determinant-based classification of acute pancreatitis severity: International multidisciplinary classification of acute pancreatitis severity: The 2013 German Edition [Einteilung des Schweregrads der akuten Pankreatitis: Internationale, multidisziplinäre klinische Klassifikation auf Basis pathogenetischer Determinanten: Deutsche Version 2013] 56
International Multidisciplinary Classification of Acute Pancreatitis Severity: The 2013 Spanish Edition 56
Mechanism of pain in chronic pancreatitis 55
Differential expression of connective tissue growth factor in inflammatory bowel disease. 55
Expression of interleukin-8 and substance P in human chronic pancreatitis 55
Neuroimmune appendicitis: a new pathological entity? 55
Pathogenesis of pain in chronic pancreatitis 55
A modified fast-track program for pancreatic surgery: A prospective single-center experience 55
Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease 55
Alterations of dna-repeats in pancreatic cancer 54
Correlations among PPARγ, DNMT1, and DNMT3B expression levels and pancreatic cancer 54
Support vector machine based on microRNA expression profiles to predict histological origin of ampullary carcinoma case report of a patient affected from adenocarcinoma of the papilla of vater with lynch syndrome 53
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial 53
Determinant-based classification of acute pancreatitis severity: An international multidisciplinary consultation 53
The role of extended resection in pancreatic adenocarcinoma: Is there good evidence-based justification? 53
Surgical aspects in management of hepato-pancreatico-biliary tumours in the elderly 52
Influence of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy: Single centre experience 52
Transforming growth factor-βs and their signaling receptors are coexpressed in Crohn's disease 52
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms 51
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management 51
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients 50
Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers 50
Desmoplastic reaction influences pancreatic cancer growth behavior 49
Key Role of Phosphoinositide 3-kinase Class IB in Pancreatic Cancer. 49
Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients 49
Genetic susceptibility to pancreatic cancer and its functional characterisation: The PANcreatic Disease ReseArch (PANDoRA) consortium 49
Mapping of Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer 48
Cathepsins and pancreatic cancer: The 2012 update. 48
Phosphatidylserine receptor in chronic pancreatitis: Evidence for a macrophage independent role 48
Chemokine receptor CXCR4: Role in gastrointestinal cancer 48
Chronic pancreatitis: The perspective of pain generation by neuroimmune interaction 48
A tumour score with multidetector spiral CT for venous infiltration in pancreatic cancer: Influence on borderline resectable 48
SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation 48
PI3K-gamma upregulation promotes proliferation and AKT activation in pancreatic cancer 47
How we do it: totally laparoscopic complete mesocolon excision for splenic flexure cancer 47
Changes of protein gene product 9.5 (PGP 9.5) immunoreactive nerves in inflamed appendix 47
Phosphoinositide 3-Kinase Class IB plays a key role in human pancreatic cancer 46
The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitis 46
Key role of Phosphoinositide 3-Kinase Class IB in pancreatic cancer 45
The neuroimmune connection in chronic pancreatisis 45
Immune cell infiltration and Growth associated protein-43 correlate with pain in chronic pancreatitis. 44
Neurokinin-2 receptor levels correlate with intensity, frequency, and duration of pain in chronic pancreatitis 44
Substance P and neprilysin in chronic pancreatitis 44
Pain and pain generation in pancreatic cancer 44
Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes 44
MRI-based clinical-radiomics model predicts tumor response before treatment in locally advanced rectal cancer 44
Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy 43
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 43
Immune cells infiltration and the expression of growth associated protein-43 expression correlate with pain in chronic pancreatisis 42
MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma 42
Genetic variants of membrane metallopeptidase genes in inflammatory bowel diseases 42
Combined modality treatments in pancreatic cancer 42
Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. 41
Cronic pancreatitis: evidence for neurogenic inflammation 41
Re: Red hot chilli consumption is harmful in patients operated for anal fissure - A randomized, double-blind, controlled study 40
Neuroimmune interactions in patients with inflammatory bowel diseases: Disease activity and clinical behavior based on Substance P serum levels 40
Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer 39
Italian consensus guidelines for chronic pancreatitis 39
Totale 5.649
Categoria #
all - tutte 23.068
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.068


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019105 0 0 0 0 0 0 0 0 0 0 3 102
2019/20201.113 209 44 56 23 95 70 131 77 125 99 163 21
2020/2021720 105 14 119 28 65 165 20 18 38 91 16 41
2021/2022595 25 28 16 99 32 10 4 38 36 5 73 229
2022/20232.049 200 312 123 269 143 366 99 183 220 24 76 34
2023/2024831 58 35 81 26 80 300 157 58 1 33 2 0
Totale 6.150